PharmAla Biotech Provides Corporate Update: U.S. Patent Granted Covering Novel Enantioselective Processes, Decision on APA-01, and Engagement of Canaccord Genuity as Exclusive Investment Banking Partner
Globe Newswire•21/08/2026•07:00 ET
0
Whiz Insights
Get started
Create a free account to read the full story.